Aratana Therapeutics Inc (NASDAQ:PETX)

11.72
Data as of Sep 02
 +0.10 / +0.86%
Today’s Change
8.21
Today|||52-Week Range
29.32
-38.64%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close11.62
Today’s open11.62
Day’s range-- - --
Volume124,882
Average volume (3 months)197,966
Market cap$342.2M
Dividend yield--
Data as of 09/02/2014

Growth & Valuation

Earnings growth (last year)+61.39%
Earnings growth (this year)-296.92%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)--
P/E ratio53.3
Price/Sales1,717.35
Price/Book3.16

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...-0.01-0.08%
NWBONorthwest Biotherape...+0.08+1.37%
XNCRXencor Inc-0.10-0.94%
SCLNSciClone Pharmaceuti...+0.11+1.60%
Data as of 09/02/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$123.0K
Annual profit (last year)-$4.3M
Net profit margin-3,485.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.